Acerus Pharmaceuticals is based in Mississauga, ON, Canada. It has raised $86M in total funding.
Acerus Pharmaceuticals funding overview
Acerus Pharmaceuticals is based in Mississauga, ON, Canada. Acerus Pharmaceuticals has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Acerus Pharmaceuticals runs through 2022; nothing later has been disclosed. Investors on record include Research Capital, First Generation Capital, J5 Acquisition. 3 distinct backers are named across the disclosed rounds.
Acerus Pharmaceuticals at a glance
Total raised
$86M
Latest round date
March 2022
Headquarters
Mississauga, ON, Canada
Notable investors
Research Capital, First Generation Capital, J5 Acquisition
Frequently asked about Acerus Pharmaceuticals funding
How much has Acerus Pharmaceuticals raised?
Acerus Pharmaceuticals has raised $86M in total disclosed funding across the rounds on record.
Who has invested in Acerus Pharmaceuticals?
Research Capital, First Generation Capital, J5 Acquisition are named among the investors backing Acerus Pharmaceuticals.
What was the latest Acerus Pharmaceuticals funding round?
No round stage has been disclosed for Acerus Pharmaceuticals.
Where is Acerus Pharmaceuticals based?
Acerus Pharmaceuticals is based in Mississauga, ON, Canada.
When did Acerus Pharmaceuticals last raise?
The last disclosed Acerus Pharmaceuticals round closed in March 2022.
Round data for Acerus Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Mississauga and backer lists below.
